Pascale Andre
Novo Nordisk
5 Papers
113 Citations
Pascale Andre is an academic researcher from Novo Nordisk. The author has contributed to research in topics: Antibody & Cytotoxicity. The author has an hindex of 4, co-authored 5 publications.
Chat about Author
Papers
Patent
Human anti-kir antibodies
Alessandro Moretta,Mariella Della Chiesa,Pascale Andre,Laurent Gauthier,Francois Romagne,Peter Andreas Nicolai Reumert Wagtmann,Ivan Svendsen,Stefan Zahn,Anders Svensson,Matthias Thorolfsson,Søren Berg Padkær,Kristian Kjaergaard,Pieter Spee,Milchael Wilken +13 more
- 02 Oct 2008
TL;DR: In this article, the authors describe human antibodies that regulate the activity of NK cells and allow a potentiation of NK cell cytotoxicity in mammalian subjects, and antibodies having antigen-binding properties similar to those of human monoclonal antibody 1-7F9 or 1-4F1.
61
Patent
Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies
Søren Berg Padkjær,Alessandro Moretta,Mariella Della Chiesa,Pascale Andre,Laurent Gauthier,Peter Andreas Nicolai Reumert Wagtmann +5 more
- 01 Jul 2004
TL;DR: In this paper, the authors present novel compositions and methods for regulating an immune response in a subject, including specific antibodies that regulate the activity of NK cells and allow a potentiation of NK cell cytotoxicity in mammalian subjects.
31
Patent
Compositions and methods for regulating NK cell activity
Søren Berg Padkjær,Alessandro Moretta,Mariella Della Chiesa,Pascale Andre,Laurent Gauthier,Peter Andreas Nicolai Reumert Wagtmann +5 more
- 10 Jun 2010
TL;DR: In this paper, the authors present novel compositions and methods for regulating an immune response in a subject, including specific antibodies that regulate the activity of NK cells and allow a potentiation of NK cell cytotoxicity in mammalian subjects.
13
Patent
Antibodies binding to receptors kir2dl1, -2, 3 but not kir2ds4 and their therapeutic use
Alessandro Moretta,Chiesa Mariella Della,Pascale Andre,Laurent Gauthier,Francois Romagne,Peter Andreas Nicolai Reumert Wagtmann,Ivan Svendsen,Stefan Zahn,Anders Svensson,Matthias Thorolfsson,Pieter Spee,Kristian Kjaergaard,Søren Berg Padkær +12 more
- 01 Jul 2005
TL;DR: In this article, the authors described human antibodies that regulate the activity of NK cells and allow a potentiation of NK cell cytotoxicity in mammalian subjects, and antibodies having antigen-binding properties similar to those of human monoclonal antibody 1-7F9 or 1-4F1.
5
Patent
Nucleic acids encoding human anti-kir antibodies
Alessandro Moretta,Mariella Della Chiesa,Pascale Andre,Laurant Gauthier,Francois Romagne,Peter Andreas Nicolai Reumert Wagtmann,Ivan Svendsen,Stefan Zahn,Anders Svensson,Matthias Thorolfsson,Søren Berg Padkjær,Kristian Kjaergaard,Petrus Johannes Loius Spee,Milchael Wilken +13 more
- 11 Jan 2012
TL;DR: In this article, the authors describe human antibodies that regulate the activity of NK cells and allow a potentiation of NK cell cytotoxicity in mammalian subjects, and antibodies having antigen-binding properties similar to those of human monoclonal antibody 1-7F9 or 1-4F1.
3